Does simultaneous TAVR and EVAR provide a viable therapeutic option in surgical high-risk patients with concurrent abdominal aortic aneurysm and severe aortic valve disease?
Surgical high-risk patients with concurrent giant abdominal aortic aneurysm and severe aortic valve disease (severe aortic regurgitation)
Simultaneous transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR)
Simultaneous TAVR and EVAR may be a viable therapeutic strategy for surgical high-risk patients presenting with both severe aortic regurgitation and a giant abdominal aortic aneurysm.
For surgical high-risk patients with concurrent abdominal aortic aneurysm and severe aortic valve disease, the simultaneous implementation of TAVR and endovascular aneurysm repair may represent a viable therapeutic option.
Building similarity graph...
Analyzing shared references across papers
Loading...
Wenfei He
Ji-Shen Guo
Zhiqiang Guo
JACC Case Reports
Guangzhou Medical University
Guangdong Academy of Medical Sciences
First Affiliated Hospital of Guangzhou Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...
He et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69bf8978f665edcd009e91c2 — DOI: https://doi.org/10.1016/j.jaccas.2026.107013